Clinical Trials Phase II & III

Clinical Trials Phase II & III: From Proof of Concept to Pivotal Evidence

Phase II and III trials generate the evidence that determines whether a medicine reaches patients. This certified learning path, developed under the expert guidance of Dr. Patricia Kay, provides clinical research professionals with the full operational and regulatory toolkit to design, manage, and deliver large-scale controlled trials that meet ICH-GCP standards and withstand regulatory review.

Course Breakdown:

• Clinical Trial Protocol: Master the structure, content, and regulatory requirements of a robust clinical trial protocol — the document that governs every decision in a Phase II or III study.
• Randomization & Blinding in Clinical Research Trials: Understand the statistical and operational principles behind randomisation and blinding, and their critical role in protecting trial validity and regulatory acceptance.
• Clinical Data Management: Learn the end-to-end process of collecting, validating, and managing clinical trial data to ensure accuracy, completeness, and ALCOA+ compliance across large multi-site studies.
• Clinical Trials: Preparing for an Audit or Inspection: Build the inspection-readiness mindset and practical skills needed to successfully navigate sponsor audits and regulatory authority inspections during Phase II/III.
• Management of the TMF and ISF: Ensure your Trial Master File and Investigator Site File are maintained to the standards required by ICH E6(R3) and regulatory inspectors throughout the trial lifecycle.
• ICH-GCP: Introduction to Good Clinical Practice: Reinforce the foundational GCP principles that underpin every aspect of Phase II and III trial conduct.
• Good Clinical Practice Training Refresher 2026 (ICH-GCP E6 R3): Apply the latest GCP updates from the E6(R3) revision to your Phase II/III operations and documentation practices.

Why Choose This Learning Path?

• Expert-Led Curriculum: Developed by Dr. Patricia Kay, a senior research management professional with over 20 years of clinical development experience across cardiovascular, immunology, and infectious disease programmes.
• Comprehensive Coverage: From protocol design and randomisation through data management, TMF governance, and inspection readiness, this path covers every operational pillar of Phase II/III trials.
• Flexible Learning: Fully self-paced and online — study around your trial commitments and revisit modules as regulatory guidance updates.
• Certification: Earn a recognised certificate validating your Phase II/III competency to sponsors, ethics committees, and regulatory bodies.

Who Should Enroll?

Whether you are a clinical research associate, trial manager, data manager, or regulatory professional transitioning into late-phase clinical operations, this learning path was designed for you. It is equally valuable for pharmaceutical and CRO teams standardising their clinical operations training across Phase II and III programmes.

Deliver the Evidence That Brings Medicines to Patients

Join thousands of life sciences professionals who have used GxP Training to build verifiable, career-defining expertise. Phase II and III trials are where reputations — and drug programmes — are made or broken. Enroll today and build the skills that pivotal trials demand.